Scandinavian ChemoTech Ownership

Stocks . Sweden . 
Stock . Scandinavian ChemoTech AB
CMOTEC-B  SEK 1.74  0.04  2.35%   
The market capitalization of Scandinavian ChemoTech is kr113.35 Million. Scandinavian ChemoTech maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Some institutional investors establish a significant position in stocks such as Scandinavian ChemoTech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Scandinavian ChemoTech, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Scandinavian ChemoTech AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Scandinavian Stock Ownership Analysis

About 26.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.19. Scandinavian ChemoTech had not issued any dividends in recent years. The entity had 1061:839 split on the 20th of April 2020. Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB is headquartered in Malmo, Sweden. Scandinavian ChemoTech is traded on Stockholm Stock Exchange in Sweden. For more info on Scandinavian ChemoTech AB please contact Stefan Frick at 46 1 0218 9300 or go to https://chemotech.se.

Scandinavian ChemoTech Outstanding Bonds

Scandinavian ChemoTech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Scandinavian ChemoTech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Scandinavian bonds can be classified according to their maturity, which is the date when Scandinavian ChemoTech AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp Bond
US235822AB96		View
Boeing Co 2196 Corp Bond
US097023DG73		View
BNP Paribas FRN Corp Bond
USF1R15XK367		View
AerCap Global Aviation Corp Bond
US00773HAA59		View

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Scandinavian Stock

Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY